The Role of Serum Procalcitonin as a Diagnostic and Prognostic Biomarker for Sepsis in Major Burn Patients: A Prospective Study

Greenhalgh D.G.: Sepsis in the burn patient: A different
problem than sepsis in the general population. Burns &
trauma, 5, 2017.
2- Permatasari A.Y., Sanjaya I.H., Widiana I.G.R., Niryana
I.W., Asmarajaya A.N., Hamid A.R.R. and Adnyana M.S.:
Role of Procalcitonin and C-reactive Protein as Marker of
Sepsis in Major Burn Patients: A Systematic Review and
Meta-analysis. Open Access Macedonian Journal of Medical
Sciences, 9 (F): 197-203, 2021.
3- Chiesa C., Panero A., Osborn J.F., Simonetti A.F. and
Pacifico L.: Diagnosis of neonatal sepsis: A clinical and
Egypt, J. Plast. Reconstr. Surg., April 2024 97
laboratory challenge. Clinical Chemistry, 50 (2): 279-287.
2004.
4- Barati M., Alinejad F., Bahar M.A., Tabrisi M.S., Shamshiri
A.R. and Karimi H.: Comparison of WBC, ESR, CRP
and PCT serum levels in septic and non-septic burn cases.
Burns, 34 (6): 770-774, 2008.
5 Xu Y., Jin X., Shao X., Zheng F. and Zhou H.: Valuable
prognostic indicators for severe burn sepsis with inhalation
lesion: Age, platelet count, and procalcitonin. Burns
& Trauma, 6, 2018.
6- Mann E.A., Wood G.L. and Wade C.E.: Use of procalcitonin
for the detection of sepsis in the critically ill burn
patient: A systematic review of the literature. Burns, 37
(4): 549-558, 2011.
7- Cabral L., Afreixo V., Santos F., Almeida L. and Paiva J.:
A. Procalcitonin for the early diagnosis of sepsis in burn
patients: A retrospective study. Burns, 43 (7): 1427-1434,
2017.
8- Lavrentieva A., Papadopoulou S., Kioumis J., Kaimakamis
E. and Bitzani M.: PCT as a diagnostic and prognostic tool
in burn patients. Whether time course has a role in monitoring
sepsis treatment. Burns, 38 (3): 356-363, 2012.
9- Jeschke M.G., Finnerty C.C., Kulp G.A., Kraft R. and
Herndon D.N.: Can we use C-reactive protein levels to
predict severe infection or sepsis in severely burned patients?
International journal of burns and trauma, 3 (3):
137, 2013.
10- Kumar H.R.N., Barreto E., Paul M.K. and Gupta A.K.:
Procalcitonin: Promising biomarker to detect sepsis in
burns A prospective study. Indian Journal of Burns, 26 (1):
87, 2018.
11- LIN J.C., CHEN Z.H. and CHEN X.D.: Elevated serum
procalcitonin predicts Gram-negative bloodstream infections
in patients with burns. Burns, 46 (1): 182-9, 2020.
12- Wu J., Hu L., Zhang G., Wu F. and He T.: Accuracy of
presepsin in sepsis diagnosis: A systematic review and meta-
analysis. PLoS One, 10 (7): e0133057, 2015.
13- Kundes M. and Kement M.: Value of procalcitonin levels
as a predictive biomarker for sepsis in pediatric patients
with burn injuries. Nigerian Journal of Clinical Practice,
22 (7): 881, 2019.
14- Meng F.S., Su L., Tang Y.Q., Wen Q., Liu Y.S. and Liu
Z.F.: Serum procalcitonin at the time of admission to the
ICU as a predictor of short-term mortality. Clinical biochemistry,
42 (10-11): 1025-31, 2009.
15- Jain S., Sinha S., Sharma S.K., Samantaray J.C., Aggrawal
P., Vikram N.K., Biswas A., Sood S., Goel M., Das M. and
Vishnubhatla S.: Procalcitonin as a prognostic marker for
sepsis: A prospective observational study. BMC research
notes, 7 (1): 1-7, 2014.
16- Liu D., Su L., Han G., Yan P. and Xie L.: Prognostic value
of procalcitonin in adult patients with sepsis: A systematic
review and meta-analysis. PloS one, 10 (6): e0129450,
2015.
17- Abdel-Hafez N.M., Saleh Hassan Y. and El-Metwally
T.H.: A study on biomarkers, cytokines, and growth factors
in children with burn injuries. Ann. Burns Fire Disasters,
20: 89-100, 2007.